Young Jonathan's Form 4 filing
Akero Therapeutics, Inc. (AKRO) · filed Aug 13, 2025
- Accession no.
- 0000950170-25-108234
- Filed
- Aug 13, 2025
- Trade date
- Aug 12, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $597.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Young JonathanCIK 0001779805 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | MOption exerciseAcquired | +12,500 | $21.10 | +$263,750 | 209,984 | Direct | |
| Aug 12, 2025 | Common Stock | SSaleDisposed | −11,151 | $47.72 | −$532,125.72 | 198,833 | Direct | |
| Aug 12, 2025 | Common Stock | SSaleDisposed | −1,349 | $48.32 | −$65,183.68 | 197,484 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Common Stock | MOption exerciseDisposed | −82,482 | $0.00 | $0 | 69,982 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.